Review Article| Volume 33, ISSUE 4, P817-833, December 2013

Download started.


Molecular Diagnosis of Hematopoietic Neoplasms

Published:October 11, 2013DOI:


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.


      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Vardiman J.W.
        • Thiele J.
        • Arber D.A.
        • et al.
        The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
        Blood. 2009; 114: 937-951
        • Alt F.W.
        • Yancopoulos G.D.
        • Blackwell T.K.
        • et al.
        Ordered rearrangement of immunoglobulin heavy chain variable region segments.
        EMBO J. 1984; 3: 1209-1219
        • Tonegawa S.
        Somatic generation of antibody diversity.
        Nature. 1983; 302: 575-581
        • Davis M.M.
        • Bjorkman P.J.
        T-cell antigen receptor genes and T-cell recognition.
        Nature. 1988; 334: 395-402
        • Tobin G.
        • Rosenquist R.
        Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
        Med Oncol. 2005; 22: 217-228
        • van Dongen J.J.
        • Langerak A.W.
        • et al.
        Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936.
        Leukemia. 2003; 17: 2257-2317
        • Bruggemann M.
        • White H.
        • Gaulard P.
        • et al.
        Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies. Report of the BIOMED-2 Concerted Action BHM4 CT98-3936.
        Leukemia. 2007; 21: 215-221
        • Aster J.C.
        • Longtine J.A.
        Detection of BCL2 rearrangements in follicular lymphoma.
        Am J Pathol. 2002; 160: 759-763
        • Sherr C.J.
        Mammalian G1 cyclins.
        Cell. 1993; 73: 1059-1065
        • Mozos A.
        • Royo C.
        • Hartmann E.
        • et al.
        SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype.
        Haematologica. 2009; 94: 1555-1562
        • Albagli-Curiel O.
        Ambivalent role of BCL6 in cell survival and transformation.
        Oncogene. 2003; 22: 507-516
        • Basso K.
        • Dalla-Favera R.
        BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis.
        Adv Immunol. 2010; 105: 193-210
        • Nakamura N.
        • Nakamine H.
        • Tamaru J.
        • et al.
        The distinction between Burkitt lymphoma and diffuse large B-Cell lymphoma with c-myc rearrangement.
        Mod Pathol. 2002; 15: 771-776
        • Kalla J.
        • Stilgenbauer S.
        • Schaffner C.
        • et al.
        Heterogeneity of the API2-MALT1 gene rearrangement in MALT-type lymphoma.
        Leukemia. 2000; 14: 1967-1974
        • Dierlamm J.
        Genetic abnormalities in marginal zone B-cell lymphoma.
        Haematologica. 2003; 88: 8-12
        • Morris S.W.
        • Kirstein M.N.
        • Valentine M.B.
        • et al.
        Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
        Science. 1995; 267: 316-317
        • Hernandez L.
        • Pinyol M.
        • Hernandez S.
        • et al.
        TRK-fused gene (TFG) is a new partner of ALK in anaplastic large cell lymphoma producing two structurally different TFG-ALK translocations.
        Blood. 1999; 94: 3265-3268
        • Breen K.A.
        • Grimwade D.
        • Hunt B.J.
        The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia.
        Br J Haematol. 2012; 156: 24-36
        • De Botton S.
        • Chevret S.
        • Sanz M.
        • et al.
        Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial.
        Br J Haematol. 2000; 111: 801-806
        • Nucifora G.
        • Birn D.J.
        • Erickson P.
        • et al.
        Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia.
        Blood. 1993; 81: 883-888
        • Le Beau M.M.
        • Larson R.A.
        • Bitter M.A.
        • et al.
        Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia. A unique cytogenetic-clinicopathological association.
        N Engl J Med. 1983; 309: 630-636
        • Kaneko Y.
        • Maseki N.
        • Takasaki N.
        • et al.
        Clinical and hematologic characteristics in acute leukemia with 11q23 translocations.
        Blood. 1986; 67: 484-491
        • Lugthart S.
        • Groschel S.
        • Beverloo H.B.
        • et al.
        Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
        J Clin Oncol. 2010; 28: 3890-3898
        • Grimwade D.
        • Hills R.K.
        • Moorman A.V.
        • et al.
        Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
        Blood. 2010; 116: 354-365
        • Marcucci G.
        • Mrozek K.
        • Bloomfield C.D.
        Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.
        Curr Opin Hematol. 2005; 12: 68-75
        • Faderl S.
        • Talpaz M.
        • Estrov Z.
        • et al.
        The biology of chronic myeloid leukemia.
        N Engl J Med. 1999; 341: 164-172
        • Verfaillie C.M.
        Biology of chronic myelogenous leukemia.
        Hematol Oncol Clin North Am. 1998; 12: 1-29
        • Gabert J.
        • Beillard E.
        • van der Velden V.H.
        • et al.
        Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia: a Europe Against Cancer program.
        Leukemia. 2003; 17: 2318-2357
        • Pozdnyakova O.
        • Miron P.M.
        • Tang G.
        • et al.
        Cytogenetic abnormalities in a series of 1,029 patients with primary myelodysplastic syndromes: a report from the US with a focus on some undefined single chromosomal abnormalities.
        Cancer. 2008; 113: 3331-3340